HRT Financial’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

HRT Financial’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,528	Closed	-$6K	–	3381
2024 Q2	$6K	Buy	+21,528	New	+$51.1K	﹤0.01%	2038
2023 Q3	–	Sell	-1,241	Closed	-$25K	–	3296
2023 Q2	$25K	Buy	+1,241	New	+$21K	﹤0.01%	2079

Other funds holding EFTR

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

HRT Financial's EFTR Position: Q3 2024 in Review

HRT Financial sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2024, closing a stake of 21,528 shares — an estimated $6K sold.

HRT Financial first reported a position in EFTR in Q2 2023 and held it in 2 quarters. The position peaked at $25K in Q2 2023. 3 funds tracked by Wall St. Rank hold EFTR as of Q3 2024.

HRT Financial reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
HRT Financial sold 21,528 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $6K.
HRT Financial first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
HRT Financial's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $25K in Q2 2023.
3 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.